Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative Susceptibility Mapping for Lesion Differentiation in Aging Multiple Sclerosis

NCT07444047 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT07444047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07444047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative Susceptibility Mapping for Lesion Differentiation in Aging Multiple Sclerosis
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Recruiting
Start date
May 11, 2026
Completion date
December 31, 2031
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral small vessel diseases, multiple sclerosis (ms)